Condition
Adaptive Radiotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Adaptive Radiotherapy clinical trials that are recruiting, at sites in 3 countries (most in China (4), Germany (1), India (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Adaptive Radiotherapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining PD‑1 immunotherapy (sintilimab) with platinum‑doublet chemotherapy and adaptive radiotherapy for stage III non‑small cell lung cancer | Phase 2 | Changsha, Hunan and 3 other locations | Recruiting | Aug 24, 2025 |
| New radiotherapy approach for cervical cancer treatment | Phase 3 | Beijing | Recruiting | Oct 15, 2024 |
| Eliminating PTV Margins in Lung Cancer Treatment | Phase 2 | Guangzhou, Guangdong | Recruiting | Aug 7, 2024 |
| Glioma adaptive radiotherapy using an AI-driven dose plan | Phase 2 | Mumbai, Maharatshtra | Recruiting | Jul 9, 2024 |
| Adaptive ultra-short radiation therapy for early prostate cancer | — | Jena | Recruiting | Apr 9, 2024 |
| MR‑guided short-course high-dose radiation for prostate cancer (SMART‑P01 & P02) | — | Beijing, Beijing Municipality | Recruiting | Jan 10, 2022 |
All recruiting trials (6)
-
Combining PD‑1 immunotherapy (sintilimab) with platinum‑doublet chemotherapy and adaptive radiotherapy for stage III non‑small cell lung cancer
This study tests whether adding the PD‑1 drug sintilimab to standard platinum‑doublet chemotherapy plus adaptive radiotherapy helps people with unresectable stage III non‑small cell lung cancer.
-
New radiotherapy approach for cervical cancer treatment
This study is testing a new type of radiation treatment for cervical cancer to see if it works as well as the standard treatment while possibly taking less time.
-
Eliminating PTV Margins in Lung Cancer Treatment
This study is testing if removing certain safety margins during a specific type of lung cancer radiation treatment can help patients feel better and have fewer side effects compared to the standard method.
-
Glioma adaptive radiotherapy using an AI-driven dose plan
This trial tests whether using AI to guide adaptive radiation can improve treatment for adults with diffuse gliomas.
-
Adaptive ultra-short radiation therapy for early prostate cancer
This study tests how well ultra-hypofractionated adaptive radiation therapy works for men with early prostate cancer and how it affects their quality of life.
-
MR‑guided short-course high-dose radiation for prostate cancer (SMART‑P01 & P02)
This trial tests MR‑guided, very short-course high‑dose radiation for men with localized or limited metastatic prostate cancer to see if it is tolerable and effective.
Related topics
Quick answers
How many Adaptive Radiotherapy clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (4 trials), Germany (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.